APOC3 Chromosome 11
Apolipoprotein C3
Upload your DNA to see your personal genotypes for variants in APOC3.
What This Gene Does
This gene encodes a protein component of triglyceride (TG)-rich lipoproteins (TRLs) including very low density lipoproteins (VLDL), high density lipoproteins (HDL) and chylomicrons. The encoded protein plays a role in role in the metabolism of these TRLs through multiple modes. This protein has been shown to promote the secretion of VLDL1, inhibit lipoprotein lipase enzyme activity, and delay catabolism of TRL remnants. Mutations in this gene are associated with low plasma triglyceride levels and reduced risk of ischemic cardiovascular disease, and hyperalphalipoproteinemia, which is characterized by elevated levels of high density lipoprotein (HDL) and HDL cholesterol in human patients. This gene and other related genes comprise an apolipoprotein gene cluster on chromosome 11. [provided by RefSeq, Sep 2017]
Gene Info
Gene Group
Apolipoproteins
Locus Type
gene with protein product
Location
11q23.3
Ensembl
ENSG00000110245
Associated Conditions (8)
Coronary heart disease
Apolipoprotein c-III deficiency
Cardiovascular phenotype
Clear cell carcinoma of kidney
Cervical cancer
Cholesterol-ester transfer protein deficiency
Apolipoprotein C-III
nonglycosylated
Key Variants
RS138326449
Conflicting classifications of pathogenicity
Coronary heart disease, Apolipoprotein c-III deficiency, Cardiovascular phenotype
Health Risk
RS140621530
Conflicting classifications of pathogenicity
Coronary heart disease, Apolipoprotein c-III deficiency, Cervical cancer
Health Risk
RS147210663
Conflicting classifications of pathogenicity
Coronary heart disease, Apolipoprotein c-III deficiency, Cardiovascular phenotype
Health Risk
RS76353203
Conflicting classifications of pathogenicity
Apolipoprotein c-III deficiency, Coronary heart disease, Cardiovascular phenotype
Health Risk
RS773670132
Conflicting classifications of pathogenicity
Cardiovascular phenotype, Cardiovascular phenotype
Health Risk
RS121918381
Pathogenic
Apolipoprotein C-III, nonglycosylated, Apolipoprotein C-III
Health Risk
RS121918382
Pathogenic
Apolipoprotein c-III deficiency, Apolipoprotein c-III deficiency
Health Risk
All Variants (7)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS138326449 | Health Risk | Conflicting classifications of pathogenicity | Coronary heart disease, Apolipoprotein c-III deficiency, Cardiovascular phenotype |
| RS140621530 | Health Risk | Conflicting classifications of pathogenicity | Coronary heart disease, Apolipoprotein c-III deficiency, Cervical cancer |
| RS147210663 | Health Risk | Conflicting classifications of pathogenicity | Coronary heart disease, Apolipoprotein c-III deficiency, Cardiovascular phenotype |
| RS76353203 | Health Risk | Conflicting classifications of pathogenicity | Apolipoprotein c-III deficiency, Coronary heart disease, Cardiovascular phenotype |
| RS773670132 | Health Risk | Conflicting classifications of pathogenicity | Cardiovascular phenotype, Cardiovascular phenotype |
| RS121918381 | Health Risk | Pathogenic | Apolipoprotein C-III, nonglycosylated, Apolipoprotein C-III |
| RS121918382 | Health Risk | Pathogenic | Apolipoprotein c-III deficiency, Apolipoprotein c-III deficiency |